Yamoto M - Search Results

1

mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.

Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, Tsujimoto M, Yamoto M, Klein-Szanto AJ, Schilder RJ, Ohmichi M, Testa JR, Kimura T. Mabuchi S, et al. Among authors: yamoto m. Clin Cancer Res. 2009 Sep 1;15(17):5404-13. doi: 10.1158/1078-0432.CCR-09-0365. Epub 2009 Aug 18. Clin Cancer Res. 2009. PMID: 19690197 Free PMC article.

2

The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.

Mabuchi Y, Yamoto M, Minami S, Umesaki N. Mabuchi Y, et al. Among authors: yamoto m. Oncol Rep. 2006 Aug;16(2):373-9. Oncol Rep. 2006. PMID: 16820918

3

Ovarian clear-cell carcinoma producing estradiol and human chorionic gonadotropin.

Kobayashi M, Hamada H, Yamoto M, Nakano R. Kobayashi M, et al. Among authors: yamoto m. Acta Obstet Gynecol Scand. 1990;69(2):183-5. doi: 10.3109/00016349009006165. Acta Obstet Gynecol Scand. 1990. PMID: 2386021

4

Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.

Kokawa K, Shikone T, Otani T, Nishiyama R, Ishii Y, Yagi S, Yamoto M. Kokawa K, et al. Among authors: yamoto m. Gynecol Oncol. 2001 May;81(2):178-83. doi: 10.1006/gyno.2001.6138. Gynecol Oncol. 2001. PMID: 11330946

5

[A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].

Kitayama S, Iwahashi M, Iwahashi M, Yamoto M, Nakano R. Kitayama S, et al. Among authors: yamoto m. Gan To Kagaku Ryoho. 1989 May;16(5):2099-101. Gan To Kagaku Ryoho. 1989. PMID: 2730095 Japanese.

6

Immunohistochemical localization of inhibin and activin subunits, activin receptors, and Smads in ovarian clear cell adenocarcinoma.

Mabuchi Y, Yamoto M, Minami S, Umesaki N. Mabuchi Y, et al. Among authors: yamoto m. Oncol Rep. 2006 Feb;15(2):291-6. Oncol Rep. 2006. PMID: 16391844

7

Expression and function of activin receptors in human endometrial adenocarcinoma cells.

Tanaka T, Toujima S, Otani T, Minami S, Yamoto M, Umesaki N. Tanaka T, et al. Among authors: yamoto m. Int J Oncol. 2003 Sep;23(3):657-63. Int J Oncol. 2003. PMID: 12888901

8

The role of tyrosine kinase in gonadotropin-induced ovulation in the rat ovary.

Shimamoto T, Yamoto M, Nakano R. Shimamoto T, et al. Among authors: yamoto m. Eur J Endocrinol. 1998 May;138(5):594-600. doi: 10.1530/eje.0.1380594. Eur J Endocrinol. 1998. PMID: 9625375

9

Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium.

Kokawa K, Shikone T, Otani T, Nishiyama R, Ishii Y, Yagi S, Yamoto M. Kokawa K, et al. Among authors: yamoto m. Hum Reprod. 2001 Oct;16(10):2211-8. doi: 10.1093/humrep/16.10.2211. Hum Reprod. 2001. PMID: 11574518

10

Production of inhibin A and inhibin B in human ovarian sex cord stromal tumors.

Yamashita K, Yamoto M, Shikone T, Minami S, Imai M, Nishimori K, Nakano R. Yamashita K, et al. Among authors: yamoto m. Am J Obstet Gynecol. 1997 Dec;177(6):1450-7. doi: 10.1016/s0002-9378(97)70090-5. Am J Obstet Gynecol. 1997. PMID: 9423750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters